Detalles de la búsqueda
1.
Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617.
Eur J Nucl Med Mol Imaging
; 47(10): 2322-2327, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32140802
2.
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.
Lancet Oncol
; 19(6): 825-833, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29752180
3.
Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis.
Eur J Nucl Med Mol Imaging
; 45(2): 323, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29152667
4.
Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis.
Eur J Nucl Med Mol Imaging
; 45(2): 262-277, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28894897
5.
SPECT/CT in musculoskeletal infections.
Semin Musculoskelet Radiol
; 18(2): 194-202, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24715450
6.
Safety and Efficacy of 90Y Selective Internal Radiation Therapy Using Glass Microspheres in Hepatocellular Carcinoma: A Southeast Asian Single-Institution Initial Experience.
J Nucl Med Technol
; 52(2): 148-151, 2024 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38839117
7.
Management of advanced prostate cancer in the Asia-Pacific region: Summary of the Asia-Pacific Advanced Prostate Cancer Consensus Conference 2023.
Asia Pac J Clin Oncol
; 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38628049
8.
"Seeing Is Believing": Additive Utility of 68Ga-PSMA-11 PET/CT in Prostate Cancer Diagnosis.
Cancers (Basel)
; 16(9)2024 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38730729
9.
Outcomes and prognostic predictors of Lu-177 PSMA radioligand therapy in metastatic castration-resistant prostate cancer (Asian Population Study).
Asia Pac J Clin Oncol
; 2023 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36999335
10.
Optimization of Bayesian penalized likelihood reconstruction for 68 Ga-prostate-specific membrane antigen-11 PET/computed tomography.
Nucl Med Commun
; 44(6): 480-487, 2023 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36917459
11.
Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis.
Eur Urol
; 84(1): 36-48, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37032189
12.
A rare case of thymoma first detected on gallium-68 PSMA PET/CT.
Eur J Nucl Med Mol Imaging
; 44(12): 2148-2149, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28765999
13.
Real-World Data on Clinical Outcomes of Patients with Liver Cancer: A Prospective Validation of the National Cancer Centre Singapore Consensus Guidelines for the Management of Hepatocellular Carcinoma.
Liver Cancer
; 10(3): 224-239, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34239809
14.
Recombinant human thyrotropin versus thyroid hormone withdrawal in an Asian population.
Endocrine
; 69(1): 126-132, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32112240
15.
Clinical outcomes of 177lutetium-prostate-specific membrane antigen therapy in advanced prostate cancer-a prospective pilot study in an Asian population.
Nucl Med Commun
; 41(7): 618-628, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32282629
16.
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer.
J Nucl Med
; 61(6): 857-865, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31732676
17.
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy.
Eur Urol Oncol
; 2(6): 670-676, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31412006
18.
Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes.
J Nucl Med
; 60(4): 517-523, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30291192
19.
Current Status and Growth of Nuclear Theranostics in Singapore.
Nucl Med Mol Imaging
; 53(2): 96-101, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31057680
20.
A descriptive analysis of remnant activity during (90)Y resin microspheres radioembolization of hepatic tumors: technical factors and dosimetric implications.
Ann Nucl Med
; 30(3): 255-61, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26692012